Barbell Medicine Podcast cover image

Episode #231: BMI Controversy and New Drug Breakthroughs

Barbell Medicine Podcast

00:00

ECNO Glutide: A New Drug That Underwent a New Study

ECNO Glutide is the latest drug to undergo a phase two study. It's kind of like creatine in a way you just take it whenever, as long as you remember to take it, it will, it'll work. I feel like with these medicines of like, we have like a thousand different ways to hit this receptor and they all cause weight loss. And so that's a matter of accessibility and cost and things like that.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app